Breaking Finance News

CounterPath, Corp. (NASDAQ:CPAH) has been downgraded to Sell in a statement by Zacks Investment Research earlier today.

Zacks Investment Research has downgraded CounterPath, Corp. (NASDAQ:CPAH) to Sell in a statement released on 10/10/2016.

Having a price of $2.06, CounterPath, Corp. (NASDAQ:CPAH) traded -1.90% lower on the day. With the last stock price down -7.34% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. CPAH has recorded a 50-day average of $2.12 and a two hundred day average of $2.22. Trade Volume was down over the average, with 1,020 shares of CPAH changing hands under the typical 12,180

Recent Performance Chart

CounterPath, Corp. (NASDAQ:CPAH)

CounterPath, Corp. has with a one year low of $1.85 and a one year high of $5.25 and has a market capitalization of $0.

General Company Details For CounterPath, Corp. (NASDAQ:CPAH)

CounterPath Corporation designs, develops and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications (UC) services, including voice, video, messaging and collaboration functionality, over their Internet Protocol (IP)-based networks. The Company's solutions range from software products to cloud-based services. Its software products include applications for smartphones, tablets and desktop computers, a Software Development Kit (SDK) for software developers seeking to add voice, video and messaging capabilities to their existing applications, and server-based software solutions for configuring, managing and supporting softphones and for deploying messaging and collaboration services. These software products are also available to customers in the form of cloud-based hosted services. The Company is focused on selling its software products to enterprises, telecommunication service providers and channel partners.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *